Qiagen (QGEN) News Today $39.52 +0.95 (+2.45%) Closing price 03:59 PM EasternExtended Trading$39.56 +0.05 (+0.13%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Qiagen (NYSE:QGEN) Cut to Hold at Baird R WBaird R W downgraded shares of Qiagen from a "strong-buy" rating to a "hold" rating in a research report on Wednesday.February 21 at 5:50 AM | marketbeat.comQiagen (NYSE:QGEN) Rating Lowered to Hold at Baird R WFebruary 21 at 1:55 AM | americanbankingnews.comQiagen (NYSE:QGEN) Sets New 1-Year Low - Should You Sell?Qiagen (NYSE:QGEN) Sets New 12-Month Low - Should You Sell?February 20 at 11:32 AM | marketbeat.comQiagen (NYSE:QGEN) Stock Rating Lowered by Robert W. BairdRobert W. Baird lowered Qiagen from an "outperform" rating to a "neutral" rating and reduced their target price for the stock from $52.00 to $42.00 in a report on Wednesday.February 20 at 7:11 AM | marketbeat.comBaird Downgrades Qiagen N.V. (QGEN)February 20 at 5:49 AM | msn.comQiagen (NYSE:QGEN) Downgraded to Neutral Rating by Robert W. BairdFebruary 20 at 2:53 AM | americanbankingnews.comElectronic Arts initiated, Workday downgraded: Wall Street's top analyst callsFebruary 19 at 11:24 AM | finance.yahoo.comOptimistic Buy Rating for Qiagen: Market Position and Strategic Advancements Drive Growth ProspectsFebruary 19 at 8:38 AM | tipranks.comQiagen downgraded to Neutral from Outperform at BairdFebruary 19 at 6:24 AM | markets.businessinsider.comFFPE Tissue Samples for Genomics Study & Analysis Market to Cross US$ 1.5 Bn by 2034 with a Robust CAGR of 5.1%, Led by Key Players BioChain Institute, Amsbio, Cureline, Discovery Life Sciences, and QIAGEN - TMRFebruary 18 at 11:13 AM | globenewswire.comInstitutional owners may take dramatic actions as Qiagen N.V.'s (NYSE:QGEN) recent 5.6% drop adds to one-year lossesFebruary 14, 2025 | finance.yahoo.comQIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific RegionFebruary 13, 2025 | finance.yahoo.comQIAGEN opens new data center in MelbourneFebruary 13, 2025 | msn.comWilliam Blair Issues Negative Estimate for Qiagen EarningsFebruary 12, 2025 | americanbankingnews.comQiagen (NYSE:QGEN) Sets New 52-Week Low on Analyst DowngradeQiagen (NYSE:QGEN) Reaches New 1-Year Low After Analyst DowngradeFebruary 10, 2025 | marketbeat.comWilliam Blair Brokers Decrease Earnings Estimates for QiagenQiagen (NYSE:QGEN - Free Report) - Stock analysts at William Blair dropped their Q1 2025 earnings per share (EPS) estimates for shares of Qiagen in a research note issued on Friday, February 7th. William Blair analyst A. Brackmann now expects that the company will post earnings per share of $0.49February 10, 2025 | marketbeat.comQiagen Enters Oversold Territory (QGEN)February 9, 2025 | nasdaq.comQiagen (QGEN) Receives a Buy from J.P. MorganFebruary 8, 2025 | markets.businessinsider.comUBS Group Cuts Qiagen (NYSE:QGEN) Price Target to $48.00UBS Group decreased their price objective on Qiagen from $50.00 to $48.00 and set a "neutral" rating on the stock in a report on Friday.February 7, 2025 | marketbeat.comQiagen N.V. (NYSE:QGEN) Q4 2024 Earnings Call TranscriptFebruary 7, 2025 | insidermonkey.comQiagen Exceeds 2024 Financial Outlook with Solid GrowthFebruary 7, 2025 | tipranks.comQiagen targets 4% CER sales growth for 2025 with key portfolio advancementsFebruary 6, 2025 | msn.comQiagen N.V. (QGEN) Q4 2024 Earnings Call TranscriptFebruary 6, 2025 | seekingalpha.comQiagen N.V. (QGEN) Stock ForecastsFebruary 6, 2025 | ca.finance.yahoo.comQiagen (QGEN) Receives a Buy from Deutsche BankFebruary 6, 2025 | markets.businessinsider.comQiagen N.V. 2024 Q4 - Results - Earnings Call PresentationFebruary 6, 2025 | seekingalpha.comQiagen (NYSE:QGEN) Shares Gap Down - Here's WhyQiagen (NYSE:QGEN) Shares Gap Down - What's Next?February 6, 2025 | marketbeat.comUBS Reaffirms Their Hold Rating on Qiagen (QGEN)February 6, 2025 | markets.businessinsider.comQiagen sees 2025 adjusted EPS at least $2.28, consensus $2.35February 6, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Hold Rating on Qiagen (QGEN)February 6, 2025 | markets.businessinsider.comQIAGEN N.V.: QIAGEN delivers solid Q4 2024 growth ahead of outlookFebruary 5, 2025 | finanznachrichten.deQiagen Earnings Review: Q4 SummaryFebruary 5, 2025 | benzinga.comQiagen reports Q4 adjusted EPS 61c, consensus 62cFebruary 5, 2025 | markets.businessinsider.comQiagen (NYSE:QGEN) Updates FY 2025 Earnings GuidanceQiagen (NYSE:QGEN) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.280- for the period, compared to the consensus estimate of 2.350. The company also issued revenue guidance of $2.1 billionillion-, compared to the consensus estimate of $2.1 billionillion.February 5, 2025 | marketbeat.comQiagen (NYSE:QGEN) Issues Q1 2025 Earnings GuidanceQiagen (NYSE:QGEN) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.500- for the period, compared to the consensus estimate of 0.500. The company also issued revenue guidance of $472.8 millionillion-, compared to the consensus estimate of $477.5 millionillion.February 5, 2025 | marketbeat.comQiagen NV (QGEN) Reports Strong Q4 and Full-Year 2024 Financial ResultsFebruary 5, 2025 | gurufocus.comQiagen (NYSE:QGEN) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPSQiagen (NYSE:QGEN - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.61 EPS for the quarter, topping analysts' consensus estimates of $0.60 by $0.01. Qiagen had a return on equity of 13.43% and a net margin of 4.73%.February 5, 2025 | marketbeat.comQIAGEN delivers solid Q4 2024 growth ahead of outlookFebruary 5, 2025 | businesswire.comQiagen gets ‘positive’ court decision reaffirming QuantiFERON-TB patentFebruary 5, 2025 | markets.businessinsider.comQiagen NV (QGEN) Q4 2024 Earnings Report Preview: What To ExpectFebruary 5, 2025 | gurufocus.comQiagen NV Wins Patent Dispute, Strengthening QuantiFERON Technology ProtectionFebruary 4, 2025 | gurufocus.comQIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patentFebruary 4, 2025 | businesswire.comQiagen NV (QGEN) Q4 2024 Earnings Report Preview: What To ExpectFebruary 4, 2025 | gurufocus.comQiagen (NYSE:QGEN) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Qiagen (NYSE:QGEN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nine research firms that are covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to thFebruary 3, 2025 | marketbeat.comQiagen Announces Managerial Share Consolidation Following Repurchase PlanJanuary 31, 2025 | tipranks.comQIAGEN N.V. Executes Share Consolidation Following Synthetic Repurchase ApprovalJanuary 31, 2025 | tipranks.comQiagen Announces Synthetic Share Repurchase and Share ConsolidationJanuary 31, 2025 | tipranks.comQIAGEN’s Share Consolidation Impacts Managerial HoldingsJanuary 31, 2025 | tipranks.comQiagen (NYSE:QGEN) Short Interest Down 18.0% in JanuaryQiagen (NYSE:QGEN - Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 3,060,000 shares, a decrease of 18.0% from the December 31st total of 3,730,000 shares. Based on an average daily volume of 864,900 shares, the short-interest ratio is presently 3.5 days. Currently, 1.4% of the shares of the stock are sold short.January 30, 2025 | marketbeat.comExchange Traded Concepts LLC Sells 258,335 Shares of Qiagen (NYSE:QGEN)Exchange Traded Concepts LLC cut its stake in shares of Qiagen (NYSE:QGEN - Free Report) by 93.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,430 shares of the company's stock after selling 258,335 sJanuary 30, 2025 | marketbeat.com Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address QGEN Media Mentions By Week QGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QGEN News Sentiment▼-0.370.60▲Average Medical News Sentiment QGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QGEN Articles This Week▼136▲QGEN Articles Average Week Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News TEVA News SMMT News GMAB News ITCI News VTRS News MRNA News RDY News PCVX News SRPT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:QGEN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
